Johnson & Johnson (JNJ) Return on equity 2016–2025
Johnson & Johnson (JNJ) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
32.9%FY2025 · since FY2016: 23.5% → 32.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 32.9% | +13.2 pp |
| FY2024 | 19.7% | -31.4 pp |
| FY2023 | 51.1% | +27.8 pp |
| FY2022 | 23.4% | -4.8 pp |
| FY2021 | 28.2% | +5.0 pp |
| FY2020 | 23.3% | -2.2 pp |
| FY2019 | 25.4% | -0.2 pp |
| FY2018 | 25.6% | +23.4 pp |
| FY2017 | 2.2% | -21.3 pp |
| FY2016 | 23.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice